Latest Breaking News On - Immunovaccine technologies inc - Page 1 : comparemela.com

BioVaxys Technology Corp Closes SECOND Tranche of Private Placement

BioVaxys Technology Corp Closes SECOND Tranche of Private Placement
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesBritish columbiaImmunovaccine technologies incPrnewswire biovaxys technology corpUnits of the companyBiovaxys technology corpVaxys technologyPrivate placementSecond trancheUnited states securities actRelapsed refractory diffuse largeb cell lymphomaFrankfurt bourseChief executive

BioVaxys Technology Corp Closes SECOND Tranche of Private Placement

BioVaxys Technology Corp Closes SECOND Tranche of Private Placement
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaUnited kingdomBiovaxys technology corpImmunovaccine technologies incPrnewswire biovaxys technology corpUnits of the companyVaxys technologyPrivate placementSecond trancheUnited states securities actRelapsed refractory diffuse largeb cell lymphomaFrankfurt bourseChief executiveChance des

BioVaxys Technology Corp Closes First Tranche of Private Placement

BioVaxys Technology Corp Closes First Tranche of Private Placement
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomBritish columbiaUnited statesImmunovaccine technologies incBiovaxys technology corpUnits of the companyPrnewswire biovaxys technology corpCanadian securities exchangeVaxys technologyFirst tranchePrivate placementEach finderFinal trancheCanadian securitiesUnited states securities actRelapsed refractory diffuse largeb cell lymphoma

BioVaxys Technology Corp Closes First Tranche of Private Placement

/PRNewswire/ BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (the "Company") is pleased to announce that it has closed the first tranche (the "First.

United kingdomUnited statesBritish columbiaPrnewswire biovaxys technology corpUnits of the companyBiovaxys technology corpCanadian securities exchangeImmunovaccine technologies incVaxys technologyFirst tranchePrivate placementEach finderFinal trancheCanadian securitiesUnited states securities actRelapsed refractory diffuse largeb cell lymphoma

BioVaxys Technology Corp : BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC

BioVaxys Technology Corp : BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesBritish columbiaKenneth kovanBiovaxys or companyHorizon technology finance corporationPrnewswire biovaxys technology corpImmunovaccine technologies incBiovaxys technology corpVaxys technologyAsset purchase agreementCompanie creditors arrangement actBiovaxys presidentChief operating officer kenneth kovanRelapsed refractory diffuse largeb cell lymphomaFrankfurt bourse